Skip to main content
SpringerLink
Log in

Health Disparities in Chronic Obstructive Pulmonary Disease

  • Chapter
Health Disparities in Respiratory Medicine

Part of the book series: Respiratory Medicine ((RM))

Abstract

Chronic obstructive pulmonary disease (COPD) is the third most common cause of death in the U.S. There are numerous forms of disparities in COPD. These range from the obvious disparities in prevalence and outcomes in different racial and ethnic groups to more subtle disparities such as how COPD is perceived by patients and the general public relative to other chronic diseases. In this review, we present the topic of disparities in COPD from a range of perspectives: definition, diagnosis, care, outcomes, policies, and public funding of research. Recent years have shown considerable movement in decreasing many of these disparities, although there remains a need for continued progress on many fronts.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. CDC. Chronic obstructive pulmonary disease among adults—United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(46):938–43.

    Google Scholar 

  2. Ford ES, Mannino DM, Zhao G, Li C, Croft JB. Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994. Chest. 2012;141(1):101–10.

    Article  PubMed  Google Scholar 

  3. Monteagudo M, Rodriguez-Blanco T, Parcet J, Penalver N, Rubio C, Ferrer M, et al. Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care. Arch Bronconeumol. 2011;47(5):226–33.

    Article  PubMed  Google Scholar 

  4. Joo MJ, Au DH, Fitzgibbon ML, McKell J, Lee TA. Determinants of spirometry use and accuracy of COPD diagnosis in primary care. J Gen Intern Med. 2011;26(11):1272–7.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Roche N, Dalmay F, Perez T, Kuntz C, Vergnenegre A, Neukirch F, et al. FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision? Respir Med. 2008;102(11):1568–74.

    Article  PubMed  Google Scholar 

  6. Lamprecht B, Schirnhofer L, Kaiser B, Buist SA, Mannino DM, Studnicka M. Subjects with discordant airways obstruction: lost between spirometric definitions of COPD. Pulm Med. 2011;2011:780215.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Damarla M, Celli BR, Mullerova HX, Pinto-Plata VM. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care. 2006;51(10):1120–4.

    PubMed  Google Scholar 

  8. Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–8.

    Article  CAS  PubMed  Google Scholar 

  9. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001;119(6):1691–5.

    Article  CAS  PubMed  Google Scholar 

  10. Miravitlles M, de la Roza C, Naberan K, Lamban M, Gobartt E, Martin A, et al. Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care. Arch Bronconeumol. 2006;42(1):3–8.

    Article  CAS  PubMed  Google Scholar 

  11. Ford ES, Croft JB, Mannino D, Wheaton AG, Zhang X, Giles WH. COPD surveillance-United States, 1999-2011. Chest J. 2013;144(1):284–305.

    Article  Google Scholar 

  12. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–32.

    Article  CAS  PubMed  Google Scholar 

  13. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–50.

    Article  PubMed  Google Scholar 

  14. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest. 2013;143(5):1395–406.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med. 2011;11:36.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007;176(12):1179–84.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med. 2011;184(4):414–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hansel NN, Washko GR, Foreman MG, Han MK, Hoffman EA, DeMeo DL, et al. Racial differences in CT phenotypes in COPD. COPD. 2013;10(1):20–7.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–81.

    Article  PubMed  Google Scholar 

  20. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.

    Article  PubMed  Google Scholar 

  21. Kaplan A. Effect of tiotropium on quality of life in COPD: a systematic review. Prim Care Respir J. 2010;19(4):315–25.

    Article  PubMed  Google Scholar 

  22. Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(10):948–55.

    Article  CAS  PubMed  Google Scholar 

  23. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–54.

    Article  CAS  PubMed  Google Scholar 

  24. Blanc PD, Eisner MD, Yelin EH, Earnest G, Balmes JR, Gregorich SE, et al. Socioeconomic gradients in tiotropium use among adults with COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):483–90.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Mamary AJ, Gaughan JP, Murphy J, Vance GB, Criner GJ, COPDGene Investigators. Disparities in COPD diagnosis and treatment are determined by region, race, gender and education. American Journal of Respiratory and Critical Care Medicine, Vol. 181, Meeting Abstracts; 2010.

    Google Scholar 

  26. Wille KM, Harrington KF, deAndrade JA, Vishin S, Oster RA, Kaslow RA. Disparities in lung transplantation before and after introduction of the lung allocation score. J Heart Lung Transplant. 2013;32(7):684–92.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Lederer DJ, Benn EK, Barr RG, Wilt JS, Reilly G, Sonett JR, et al. Racial differences in waiting list outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(4):450–4.

    Article  PubMed  Google Scholar 

  28. de Oca MM, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Muiño A, et al. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities. The Proyecto Latinoamericano de Investigación en Obstrucción Pulmonar (PLATINO) Study. Chest J. 2009;136(1):71–8.

    Article  Google Scholar 

  29. Garcia-Aymerich J, Serra Pons I, Mannino DM, Maas AK, Miller DP, Davis KJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax. 2011;66(7):585–90.

    Article  PubMed  Google Scholar 

  30. Elixhauser A, Au DH, Podulka J. Readmissions for chronic obstructive pulmonary disease, 2008: statistical brief #121. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Rockville; 2011.

    Google Scholar 

  31. Han MK, Curran-Everett D, Dransfield MT, Criner GJ, Zhang L, Murphy JR, et al. Racial differences in quality of life in patients with COPD. Chest. 2011;140(5):1169–76.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health. 2011;65(1):26–34.

    Article  CAS  PubMed  Google Scholar 

  33. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 Suppl):121S–6.

    Article  PubMed  Google Scholar 

  34. Gillum LA, Gouveia C, Dorsey ER, Pletcher M, Mathers CD, McCulloch CE, et al. NIH disease funding levels and burden of disease. PLoS One. 2011;6(2), e16837.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32–43.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Arne M, Emtner M, Janson S, Wilde-Larsson B. COPD patients perspectives at the time of diagnosis: a qualitative study. Prim Care Respir J. 2007;16(4):215–21.

    Article  PubMed  Google Scholar 

  37. US Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General. Atlanta: US Department of Health and Human Services; 2014.

    Google Scholar 

  38. Centers for Disease Control and Prevention. Public health strategic framework for COPD prevention. Washington, DC: Centers for Disease Control and Prevention; 2011.

    Google Scholar 

  39. Najafzadeh M, Marra CA, Lynd LD, Sadatsafavi M, FitzGerald JM, McManus B, et al. Future impact of various interventions on the burden of COPD in Canada: a dynamic population model. PLoS One. 2012;7(10), e46746.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol. 2000;53(7):755–61.

    Article  CAS  PubMed  Google Scholar 

  41. Ferre A, Fuhrman C, Zureik M, Chouaid C, Vergnenegre A, Huchon G, et al. Chronic bronchitis in the general population: influence of age, gender and socio-economic conditions. Respir Med. 2012;106(3):467–71.

    Article  PubMed  Google Scholar 

  42. Kanervisto M, Vasankari T, Laitinen T, Heliovaara M, Jousilahti P, Saarelainen S. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011;105(8):1140–6.

    Article  PubMed  Google Scholar 

  43. Yin P, Zhang M, Li Y, Jiang Y, Zhao W. Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health. 2011;11:586.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Danielsson P, Olafsdottir IS, Benediktsdottir B, Gislason T, Janson C. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden—the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012;6(2):120–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge funding by the Patient-Centered Outcomes Research Institute (CE-1304-6490 and IH-12-11-4365; Krishnan)

Conflict of Interest Statement: DMM has served as a consultant for Boehringer Ingelheim, GlaxoSmithKline, Astra-Zeneca, Novartis, Merck and Forest and has received research grants from GlaxoSmithKline, Novartis, Boehringer-Ingelheim, Forest and Pfizer. MS, JK. JLS, and SC report no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, 111 Washington Avenue, Lexington, KY, 40536, USA

    Miriam Siegel & David M. Mannino M.D.

  2. Breathe Chicago Center, Division of Pulmonary, Critical Care, Sleep & Allergy, University of Illinois in Chicago, Chicago, IL, USA

    Jerry A. Krishnan

  3. The COPD Foundation, Washington, DC, USA

    Jamie Lamson-Sullivan & Scott Cerreta

Authors
  1. Miriam Siegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerry A. Krishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jamie Lamson-Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Scott Cerreta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David M. Mannino M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David M. Mannino M.D. .

Editor information

Editors and Affiliations

  1. Arizona Respiratory Center and Departmen, University of Arizona Arizona Respiratory Center and Departmen, TUCSON, Arizona, USA

    Lynn B. Gerald

  2. Arizona Respiratory Center and Departmen, University of Arizona Arizona Respiratory Center and Departmen, Tucson, Arizona, USA

    Cristine E. Berry

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Siegel, M., Krishnan, J.A., Lamson-Sullivan, J., Cerreta, S., Mannino, D.M. (2016). Health Disparities in Chronic Obstructive Pulmonary Disease. In: Gerald, L., Berry, C. (eds) Health Disparities in Respiratory Medicine. Respiratory Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-23675-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23675-9_10

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-23674-2

  • Online ISBN: 978-3-319-23675-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation